Ardent Health (ARDT) | Financial Analysis & Statements
Ardent Health Partners Inc. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
1.6B
Gross Profit
676.2M
42.13%
Operating Income
104.8M
6.53%
Net Income
74.3M
4.63%
Balance Sheet Metrics
Total Assets
5.3B
Total Liabilities
3.6B
Shareholders Equity
1.7B
Debt to Equity
2.14
Cash Flow Metrics
Operating Cash Flow
277.4M
Free Cash Flow
139.4M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Ardent Health Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 6.3B | 6.0B | 5.4B | 5.1B | 4.9B |
| Cost of Goods Sold | 3.7B | 3.6B | - | - | - |
| Gross Profit | 2.6B | 2.4B | - | - | - |
| Gross Margin % | 40.9% | 40.2% | 0.0% | 0.0% | 0.0% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | 1.5B | 1.3B | 3.6B | 3.4B | 3.1B |
| Other Operating Expenses | 647.3M | 496.2M | 1.4B | 1.4B | 1.2B |
| Total Operating Expenses | 2.1B | 1.8B | 5.1B | 4.8B | 4.3B |
| Operating Income | 325.6M | 405.8M | 209.4M | 217.0M | 436.6M |
| Operating Margin % | 5.1% | 6.8% | 3.9% | 4.2% | 9.0% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 55.2M | 65.6M | 65.4M | 82.1M | 93.8M |
| Other Non-Operating Income | 16.0M | 22.9M | -287.0K | 176.5M | -46.8M |
| Pre-tax Income | 286.4M | 363.1M | 143.7M | 311.5M | 295.9M |
| Income Tax | 56.2M | 63.4M | 20.8M | 46.1M | 51.3M |
| Effective Tax Rate % | 19.6% | 17.4% | 14.5% | 14.8% | 17.3% |
| Net Income | 230.1M | 299.7M | 122.9M | 265.4M | 244.6M |
| Net Margin % | 3.6% | 5.0% | 2.3% | 5.2% | 5.0% |
| Key Metrics | |||||
| EBITDA | 504.6M | 578.3M | 351.9M | 531.7M | 579.9M |
| EPS (Basic) | - | $1.59 | $0.36 | $1.34 | $1.09 |
| EPS (Diluted) | - | $1.58 | $0.36 | $1.34 | $1.09 |
| Basic Shares Outstanding | - | 132439695 | 140963328 | 140963328 | 140963328 |
| Diluted Shares Outstanding | - | 132439695 | 140963328 | 140963328 | 140963328 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Ardent Health Balance Sheet From 2018 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2018 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 709.6M | 556.8M | 437.6M | 456.1M | 59.7M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 686.1M | 743.0M | 775.5M | 603.4M | 529.1M |
| Inventory | 118.6M | 115.1M | 105.5M | 107.2M | 84.8M |
| Other Current Assets | 431.9M | 304.1M | 222.3M | 173.6M | 78.2M |
| Total Current Assets | 2.1B | 1.8B | 1.6B | 1.4B | 838.1M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 2.5B | 2.4B | 2.3B | 2.3B | 691.1M |
| Goodwill | 1.8B | 1.8B | 1.8B | 1.8B | 1.7B |
| Intangible Assets | 89.3M | 76.9M | 76.9M | 76.9M | 77.8M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 118.6M | 155.3M | 179.6M | 157.8M | 146.1M |
| Total Non-Current Assets | 3.2B | 3.1B | 3.1B | 3.1B | 1.9B |
| Total Assets | 5.3B | 5.0B | 4.7B | 4.5B | 2.7B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 457.9M | 401.2M | 474.5M | 320.8M | 230.4M |
| Short-term Debt | 76.9M | 55.6M | 61.0M | 58.4M | 9.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | 7.2M | 8.0M |
| Total Current Liabilities | 1.0B | 945.4M | 994.1M | 808.6M | 555.2M |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.2B | 2.2B | 2.3B | 2.3B | 1.3B |
| Deferred Tax Liabilities | - | - | - | - | - |
| Other Non-Current Liabilities | 317.7M | 261.7M | 76.0M | 72.5M | 39.0M |
| Total Non-Current Liabilities | 2.6B | 2.5B | 2.7B | 2.6B | 1.4B |
| Total Liabilities | 3.6B | 3.4B | 3.6B | 3.4B | 2.0B |
| Equity | |||||
| Common Stock | - | - | - | - | - |
| Retained Earnings | 501.6M | 365.8M | 155.5M | 101.5M | -119.9M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.7B | 1.5B | 1.1B | 1.1B | 759.1M |
| Key Metrics | |||||
| Total Debt | 2.3B | 2.3B | 2.4B | 2.4B | 1.3B |
| Working Capital | 1.0B | 887.3M | 624.0M | 600.7M | 282.9M |
Balance Sheet Composition
Ardent Health Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 230.1M | 299.7M | 129.0M | 265.4M | 244.6M |
| Depreciation & Amortization | 155.7M | 146.3M | 140.8M | 138.2M | 137.2M |
| Stock-Based Compensation | 39.3M | 18.0M | 904.0K | 611.0K | 549.0K |
| Working Capital Changes | 118.1M | -73.3M | -42.6M | 804.0K | -65.7M |
| Operating Cash Flow | 592.4M | 415.5M | 237.1M | -20.3M | 120.7M |
| Investing Activities | |||||
| Capital Expenditures | -211.9M | -187.5M | -137.4M | -151.1M | -139.0M |
| Acquisitions | -2.5M | -31.2M | 0 | 206.4M | -2.3M |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -214.2M | -220.5M | -138.0M | 46.6M | -139.8M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | 0 | 0 | -174.8M | -62.1M |
| Debt Issuance | 0 | 3.6M | 6.6M | 878.0K | 1.2B |
| Debt Repayment | -8.0M | -108.4M | -138.6M | -17.3M | -1.3B |
| Financing Cash Flow | -103.5M | 24.6M | -227.3M | -270.3M | -283.9M |
| Free Cash Flow | 258.6M | 127.5M | 84.3M | -189.5M | 7.9M |
| Net Change in Cash | 274.8M | 219.7M | -128.2M | -244.1M | -303.0M |
Cash Flow Trend
Ardent Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
10.26
Forward P/E
8.44
Price to Book
1.09
Price to Sales
0.22
PEG Ratio
8.44
Profitability Ratios
Profit Margin
2.15%
Operating Margin
6.53%
Return on Equity
14.35%
Return on Assets
3.97%
Financial Health
Current Ratio
1.97
Debt to Equity
137.57
Per Share Data
EPS (TTM)
$0.96
Book Value per Share
$9.02
Revenue per Share
$44.93
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ARDT | 1.4B | 10.26 | 1.09 | 14.35% | 2.15% | 137.57 |
| HCA Healthcare | 106.0B | 16.86 | -38.44 | -244.82% | 8.97% | -17.57 |
| Tenet Healthcare | 16.5B | 12.17 | 3.88 | 27.02% | 6.60% | 160.79 |
| Surgery Partners | 1.9B | 2,956.00 | 1.09 | 2.76% | -2.35% | 114.51 |
| Pediatrix Medical | 1.9B | 11.88 | 2.16 | 20.28% | 8.64% | 73.29 |
| Astrana Health | 1.9B | 73.30 | 2.12 | 4.49% | 0.71% | 193.10 |
Financial data is updated regularly. All figures are in the company's reporting currency.






